Détail de l'auteur
Auteur M. HICKMAN |
Documents disponibles écrits par cet auteur (112)
Article : Périodique
J. GREBELY ; S. LARNEY ; A. PEACOCK ; S. COLLEDGE ; J. LEUNG ; M. HICKMAN ; P. VICKERMAN ; S. BLACH ; E. B. CUNNINGHAM ; K. DUMCHEV ; M. LYNSKEY ; J. STONE ; A. TRICKEY ; H. RAZAVI ; R. P. MATTICK ; M. FARRELL ; G. J. DORE ; L. DEGENHARDT |BACKGROUND AND AIMS: People who have recently injected drugs are a priority population in efforts to achieve hepatitis C virus (HCV) elimination. This study estimated the prevalence and number of people with recent injecting drug use living with[...]Article : Périodique
A. PEACOCK ; J. LEUNG ; S. LARNEY ; S. COLLEDGE ; M. HICKMAN ; J. REHM ; G. A. GIOVINO ; R. WEST ; W. HALL ; P. GRIFFITHS ; R. ALI ; L. GOWING ; J. MARSDEN ; A. J. FERRARI ; J. GREBELY ; M. FARRELL ; L. DEGENHARDT |AIMS: This review provides an up-to-date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of disease. Limitations in the data are also discussed, including how these can be addresse[...]Rapport
OEDT = EMCDDA ; M. HICKMAN, Éditeur scientifique ; N. K. MARTIN, Éditeur scientifique ; I. GIRAUDON ; L. WIESSING ; D. HEDRICH ; E. KALAMARA ; P. GRIFFITHS ; R. SIMON | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2016FRANÇAIS : L'hépatite C est une maladie infectieuse du foie causée par le virus de l'hépatite C (VHC) qui peut être transmis par le sang. Environ 115 millions de personnes à travers le monde ont été infectées à un moment donné de leur vie par l[...]Périodique
A. JUDD ; M. HICKMAN ; A. RENTON ; G. STIMSON | 1999FRANÇAIS : Dans cet éditorial, les auteurs examinent diverses données épidémiologiques concernant les évolutions de prévalence des infections par les virus du sida et de l'hépatite C chez les usagers de drogues par voie intraveineuse et ce dan[...]Périodique
A. JUDD ; G. M. HUNTER ; MACONOCHIE N. ; M. HICKMAN ; J. V. PARRY ; RENTON A. M. ; G. V. STIMSON | 1999FRANÇAIS : Des enquêtes ont été menées auprès d'usagers de drogues, recrutés dans des structures de traitement ou de proximité du Grand Londres, en 1990 (173 personnes), 1991 (111 personnes), 1992 (128 personnes), 1993 (146 personnes) et en 199[...]Article : Périodique
B. M. MATHERS ; L. DEGENHARDT ; H. ALI ; L. WIESSING ; M. HICKMAN ; R. P. MATTICK ; B. MYERS ; A. AMBEKAR ; S. A. STRATHDEE ; Reference Group to the UN on HIV and Injecting Drug Use |Background: Previous reviews have examined the existence of HIV prevention, treatment, and care services for injecting drug users (IDUs) worldwide, but they did not quantify the scale of coverage. We undertook a systematic review to estimate nat[...]Périodique
S. WILLIAMS ; M. HICKMAN ; BOTTLE A. ; P. AYLIN | 2004FRANÇAIS : Quelques données chiffrées sur les admissions à lhôpital en Angleterre et au Pays de Galles sur de 1996 à 2003.Article : Périodique
In the United Kingdom, as in many places, cannabis use is considered substantially within a criminal justice rather than a public health paradigm with prevention policy embodied in the Misuse of Drugs Act. In 2002 the maximum custodial sentence [...]Périodique
J. MACLEOD ; R. OAKES ; OPPENKOWSKI T. ; H. STOKES-LAMPARD ; A. COPELLO ; I. CROME ; G. D. SMITH ; M. EGGER ; M. HICKMAN ; A. JUDD | 2004ENGLISH : Recreational use of illicit drugs (i.e. use not associated with a diagnosed drug problem) may cause psychological and social harm. A recent systematic review found that evidence for this was equivocal. Extensive evidence was only ava[...]Article : Périodique
Concentrations of metabolites of illicit drugs in sewage water can be measured with great accuracy and precision, thanks to the development of sensitive and robust analytical methods. Based on assumptions about factors including the excretion pr[...]Article : Périodique
Z. WARD ; L. PLATT ; S. SWEENEY ; V. D. HOPE ; L. MAHER ; S. HUTCHINSON ; N. PALMATEER ; J. SMITH ; N. CRAINE ; A. TAYLOR ; N. MARTIN ; R. AYRES ; J. DILLON ; M. HICKMAN ; P. VICKERMAN |Aims: To estimate the impact of existing high-coverage needle and syringe provision (HCNSP, defined as obtaining more than one sterile needle and syringe per injection reported) and opioid substitution therapy (OST) on hepatitis C virus (HCV) tr[...]Article : Périodique
J. STRANG ; W. HALL ; M. HICKMAN ; S. M. BIRD |Objective. To evaluate the impact of introduction of supervision of methadone dosing on deaths related to overdose of methadone in Scotland and England between 1993 and 2008 while controlling for increased prescribing of methadone. Design. Anal[...]Périodique
A. JUDD ; M. HICKMAN ; S. JONES ; T. McDONALD ; J. V. PARRY ; G. V. STIMSON ; A. J. HALL | 2005In England, the low prevalence of HIV among injecting drug users during the 1990s was attributed in part to the introduction of harm reduction interventions in the late 1980s. Also, the prevalence of hepatitis C virus in the late 1990s was thoug[...]Article : Périodique
S. A. McDONALD ; A. McAULEY ; M. HICKMAN ; S. M. BIRD ; A. WEIR ; K. TEMPLETON ; R. GUNSON ; S. J. HUTCHINSON |Background: In Europe, North America, and Australia, mortality due to drug-related (DR) causes amongst people who inject drugs (PWID) is a major issue. Our objective was to characterise temporal trends in DR mortality rates in a large cohort of [...]Article : Périodique
M. HICKMAN ; HIGGINS V. ; V. HOPE ; M. A. BELLIS ; K. TILLING ; A. WALKER ; J. HENRY |Study objective: To estimate the prevalence of injecting drug use (IDU) in three cities in England and to measure the coverage of key public health indicators. Design: Capture-recapture techniques with covariate effects. Setting: Liverpool, Brig[...]Article : Périodique
L. T. TRAN ; A. PEACOCK ; S. COLLEDGE ; S. MEMEDOVIC ; J. GREBELY ; J. LEUNG ; S. LARNEY ; A. TRICKEY ; J. STONE ; P. VICKERMAN ; M. HICKMAN ; L. DEGENHARDT |Background: Injecting risk behaviour, such as receptive sharing of injecting equipment and/or re-using one's equipment, is associated with bloodborne virus transmission and infections in people who inject drugs (PWID). We aimed to estimate preva[...]Article : Périodique
E. B. CUNNINGHAM ; A. WHEELER ; B. HAJARIZADEH ; C. E. FRENCH ; R. ROCHE ; A. D. MARSHALL ; G. FONTAINE ; A. CONWAY ; S. BAJIS ; B. M. VALENCIA ; J. PRESSEAU ; J. W. WARD ; L. DEGENHARDT ; G. J. DORE ; M. HICKMAN ; P. VICKERMAN ; J. GREBELY |Background: With the advent of direct acting antiviral (DAA) therapies for the treatment of hepatitis C virus (HCV), the World Health Organization recommended a goal to eliminate HCV as a public health threat globally by 2030. With the majority [...]Article : Périodique
N. PALMATEER ; V. HAMILL ; A. BERGENSTROM ; H. BLOOMFIELD ; L. GORDON ; J. STONE ; H. FRASER ; T. SEYLER ; Y. DUAN ; R. TRAN ; K. TRAYNER ; C. BIGGAM ; S. SMITH ; P. VICKERMAN ; M. HICKMAN ; S. HUTCHINSON |Background: Hepatitis C virus (HCV) and HIV remain prevalent among people who inject drugs (PWID) and transmission is usually associated with injecting risk behaviour (IRB). We update a 2011 review of reviews (RoR) to assess the latest evidence [...]Article : Périodique
G. J. MACARTHUR ; E. VAN VELZEN ; N. E. PALMATEER ; J. KIMBER ; A. PHARRIS ; V. HOPE ; A. TAYLOR ; K. ROY ; E. ASPINALL ; D. GOLDBERG ; T. RHODES ; D. HEDRICH ; M. SALMINEN ; M. HICKMAN ; S. J. HUTCHINSON |BACKGROUND: Injecting drug use is a major risk factor for the acquisition and transmission of HIV and Hepatitis C virus (HCV). Prevention of these infections among people who inject drugs (PWID) is critical to reduce ongoing transmission, morbid[...]Article : Périodique
A. TAYLOR ; A. MUNRO ; E. ALLEN ; K. DUNLEAVY ; S. CAMERON ; L. MILLER ; M. HICKMAN |AIMS. To estimate hepatitis C virus (HCV) incidence and HCV risk among Scottish prisoners. DESIGN. National sero-behavioural survey; dried blood spots were collected in order to identify recent HCV infections (i.e. HCV antibody-negative and HCV[...]Article : Périodique
S. LARNEY ; H. JONES ; T. RHODES ; M. HICKMAN |Epidemiology is a core discipline generating evidence to inform and drive drug policy. In this essay, we speculate on what the future of drug epidemiology might become. We highlight for attention two areas shaping the future of drug epidemiology[...]Article : Périodique
G. M. HUNTER ; G. V. STIMSON ; A. JUDD ; S. JONES ; M. HICKMAN |FRANÇAIS : Buts : mesurer le comportement à risque chez des usagers de drogue intraveineux (UDI) à l'aide du questionnaire sur les risques de l'injection (QRI). Méthodes : les données ont été analysées à partir de la première enquête multi-site[...]Périodique
L. PLATT ; M. WALL ; T. RHODES ; A. JUDD ; M. HICKMAN ; L. JOHNSTON ; A. RENTON ; N. BOBROVA ; SARANG A. | 2006ENGLISH : Evidence suggests rapid diffusion of injecting drug use and associated outbreaks of HIV among injecting drug users (IDUs) in the Russian Federation and Eastern Europe. There remains a need for research among non-treatment and communi[...]Article : Périodique
H. FRASER ; N. K. MARTIN ; H. BRUMMER-KORVENKONTIO ; P. CARRIERI ; O. DALGARD ; J. DILLON ; D. GOLDBERG ; S. HUTCHINSON ; M. JAUFFRET-ROUSTIDE ; M. KABERG ; A. A. MATSER ; M. MATICIC ; H. MIDGARD ; V. MRAVCIK ; A. OVREHUS ; M. PRINS ; J. REIMER ; G. ROBAEYS ; B. SCHULTE ; D. K. VAN SANTEN ; R. ZIMMERMANN ; P. VICKERMAN ; M. HICKMAN |BACKGROUND & AIMS: Prevention of hepatitis C virus (HCV) transmission among people who inject drugs (PWID) is critical for eliminating HCV in Europe. We estimated the impact of current and scaled-up HCV treatment with and without scaling up opio[...]Article : Périodique
J. STONE ; N. K. MARTIN ; M. HICKMAN ; S. J. HUTCHINSON ; E. ASPINALL ; A. TAYLOR ; A. MUNRO ; K. DUNLEAVY ; E. PETERS ; P. BRAMLEY ; P. C. HAYES ; D. J. GOLDBERG ; P. VICKERMAN |Background and Aims: People who inject drugs (PWID) experience high incarceration rates, and previous incarceration is associated with elevated hepatitis C virus (HCV) transmission risk. In Scotland, national survey data indicate lower HCV incid[...]Article : Périodique
B. M. MATHERS ; L. DEGENHARDT ; C. BUCELLO ; J. LEMON ; L. WIESSING ; M. HICKMAN |FRANÇAIS : Objectif : Examiner systématiquement les études de cohortes de la mortalité chez les toxicomanes par injection, étudier les taux de mortalité et les causes de décès dans ce groupe, et identifier les variables, au niveau des participa[...]Article : Périodique
L. DEGENHARDT ; C. BUCELLO ; B. MATHERS ; C. BRIEGLEB ; H. ALI ; M. HICKMAN ; J. MCLAREN |AIMS: To review the literature on mortality among dependent or regular users of opioids across regions, according to specific causes, and related to a number of demographic and clinical variables. METHODS: Multiple search strategies included sea[...]Article : Périodique
M. HICKMAN ; D. DE ANGELIS ; H. JONES ; R. J. HARRIS ; N. WELTON ; A. E. ADES |The quality of the evidence on estimating drug-related harm is not yet as advanced as that for intervention effectiveness. Multiple parameter evidence synthesis offers a potential solution, in which 'all available evidence' is combined into a si[...]Article : Périodique
L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN |Aims: To estimate the effects of needle and syringe programmes (NSP) and opioid substitution therapy (OST), alone or in combination, for preventing acquisition of hepatitis C virus (HCV) in people who inject drugs (PWID). Methods: Systematic re[...]Article : Périodique
L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN |Review question: We examine research on the effect of needle syringe programmes (NSP) and opioid substitution treatment (OST) in reducing the risk of becoming infected with the hepatitis C virus. Background: There are around 114.9 million peopl[...]Article : Périodique
V. D. HOPE ; J. V. PARRY ; F. NCUBE ; M. HICKMAN |Background: The extent of intentional or accidental subcutaneous and intramuscular injections and the factors associated with these have rarely been studied among people who inject drugs, yet these may play an important role in the acquisition b[...]Article : Périodique
G. J. MACARTHUR ; S. MINOZZI ; N. MARTIN ; P. VICKERMAN ; S. DEREN ; J. BRUNEAU ; L. DEGENHARDT ; M. HICKMAN |Objective: To quantify the effect of opiate substitution treatment in relation to HIV transmission among people who inject drugs. Design: Systematic review and meta-analysis of prospective published and unpublished observational studies. Data [...]Périodique
J. PARSONS ; M. HICKMAN ; P. J. TURNBULL ; T. McSWEENEY ; G. V. STIMSON ; A. JUDD ; K. ROBERTS | 2002FRANÇAIS : Le nombre de seringues distribuées en avril 1997 est estimé à 1 707 000 et celui de l'année à 27 millions, à partir de 2000 lieux d'échange dans le Royaume-Uni. Le nombre de seringues distribuées en Ecosse est 3 à 4 fois plus bas que[...]Article : Périodique
K. P. HAYHURST ; M. PIERCE ; M. HICKMAN ; T. SEDDON ; G. DUNN ; J. KEANE ; T. MILLAR |Background: Although evidence points to a strong link between illicit drug use and crime, robust evidence for temporal order in the relationship is scant. We carried out a systematic review to assess the evidence for pathways through opiate/crac[...]NouveautéArticle : Périodique
J. HERON ; J. MACLEOD ; M. R. MUNAFO ; R. MELOTTI ; G. LEWIS ; K. TILLING ; M. HICKMAN |AIMS: Teenagers in the UK report some of the highest rates of alcohol use in Europe. We identify patterns of alcohol use in early adolescence and relate these to hazardous and harmful alcohol use at age 16. METHODS: In a UK birth cohort, we an[...]Article : Périodique
M. TAYLOR ; S. M. COLLIN ; M. R. MUNAFO ; J. MACLEOD ; M. HICKMAN ; J. HERON |Background: Evidence on the role of cannabis as a gateway drug is inconsistent. We characterise patterns of cannabis use among UK teenagers aged 13-18 years, and assess their influence on problematic substance use at age 21 years. Methods: We u[...]Article : Périodique
Background and Aims: Peer-led interventions may offer a beneficial approach in preventing substance use, but their impact has not yet been quantified. We conducted a systematic review to investigate and quantify the effect of peer-led interventi[...]Article : Périodique
E. F. KANER ; F. R. BEYER ; C. GARNETT ; D. CRANE ; J. BROWN ; C. MUIRHEAD ; J. REDMORE ; A. O'DONNELL ; J. J. NEWHAM ; F. DE VOCHT ; M. HICKMAN ; H. BROWN ; G. MANIATOPOULOS ; S. MICHIE |Review question: We aimed to find out if personalised advice to reduce heavy drinking provided using a computer or mobile device is better than nothing or printed information. We also compared advice provided using a computer or mobile device to[...]Article : Périodique
F. R. BEYER ; R. P. W. KENNY ; E. JOHNSON ; D. M. CALDWELL ; C. GARNETT ; S. RICE ; J. SIMPSON ; C. ANGUS ; D. CRAIG ; M. HICKMAN ; S. MICHIE ; E. F. S. KANER |AIM: To compare the effectiveness of practitioner versus digitally delivered interventions for reducing hazardous and harmful alcohol consumption. DESIGN: Systematic review and network meta-analysis comprising comprehensive search for randomise[...]Article : Périodique
V. D. HOPE ; A. JUDD ; M. HICKMAN |OBJECTIVES: This study sought to establish the prevalence of hepatitis C antibodies (anti-HCV) and hepatitis B antibodies (anti-HBc) among injection drug users in England and Wales. METHODS: A voluntary cross-sectional survey collected oral flu[...]Périodique
Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study
T. RHODES ; L. PLATT ; S. MAXIMOVA ; E. KOSHKINA ; N. LATISHEVSKAYA ; M. HICKMAN ; A. RENTON ; N. BOBROVA ; T. McDONALD ; J. V. PARRY | 2006Objectives: To estimate the prevalence of HIV, hepatitis C virus (HCV) and syphilis in injecting drug users (IDUs) in Russia. Methods: Unlinked anonymous cross-sectional survey of 1473 IDUs recruited from non-treatment settings in Moscow, Volgog[...]Périodique
A. JUDD ; G. V. STIMSON ; M. HICKMAN ; G. M. HUNTER ; S. JONES ; J. V. PARRY ; P. MADDEN | 2000FRANÇAIS : 753 usagers de drogues injectables (UDVIs), recrutés dans 7 centres d'accueil anglais en 1997 et 1998, ont répondu à un questionnaire et ont fait l'objet d'un dépistage anonyme du VIH. La majorité était des hommes (71,1%) et près d'u[...]Article : Périodique
L. DEGENHARDT ; B. MATHERS ; P. VICKERMAN ; T. RHODES ; C. LATKIN ; M. HICKMAN |HIV can spread rapidly between people who inject drugs (through injections and sexual transmission), and potentially the virus can pass to the wider community (by sexual transmission). Here, we summarise evidence on the effectiveness of individu[...]Article : Périodique
H. E. JONES ; N. J. WELTON ; A. E. ADES ; M. PIERCE ; W. DAVIES ; B. COLEMAN ; T. MILLAR ; M. HICKMAN |Background and Aims: Capture-recapture (CRC) analysis is recommended for estimating the prevalence of problem drug use or people who inject drugs (PWID). We aim to demonstrate how naive application of CRC can lead to highly misleading results, a[...]Article : Périodique
J. MACLEOD ; R. OAKES ; A. COPELLO ; I. CROME ; M. EGGER ; M. HICKMAN ; OPPENKOWSKI T. ; H. STOKES-LAMPARD ; G. DAVEY SMITH |BACKGROUND: Use of illicit drugs, particularly cannabis, by young people is widespread and is associated with several types of psychological and social harm. These relations might not be causal. Causal relations would suggest that recreational d[...]Périodique
T. RHODES ; J. KIMBER ; W. SMALL ; J. FITZGERALD ; T. KERR ; M. HICKMAN ; G. HOLLOWAY | 2006Background: One key structural dimension in the distribution of drug-related harm associated with injecting drug use is the injecting environment. Epidemiological evidence associates elevated blood-borne viral risk with injecting in 'public' and[...]Article : Périodique
J. GREBELY ; G. ROBAEYS ; P. BRUGGMANN ; A. AGHEMO ; M. BACKMUND ; J. BRUNEAU ; J. BYRNE ; O. DALGARD ; J. J. FELD ; M. HELLARD ; M. HICKMAN ; A. KAUTZ ; A. LITWIN ; A. R. LLOYD ; S. MAUSS ; M. PRINS ; T. SWAN ; M. SCHAEFER ; L. E. TAYLOR ; G. J. DORE |Dans les pays à revenus élevés, la majorité des infections par le virus de l'hépatite C (VHC) nouvelles et existantes se produisent chez usagers de drogues par injection (UDI). Dans de nombreux pays à revenus faibles et moyens, de vastes épidémi[...]Article : Périodique
This article discusses approaches to assessing the size of the illicit market for powder cocaine, and the inherent difficulties of this issue. It describes recent attempts to investigate more accurate measures of the prevalence and extent of use[...]Article : Périodique
J. GREBELY ; J. BRUNEAU ; J. V. LAZARUS ; O. DALGARD ; P. BRUGGMANN ; C. TRELOAR ; M. HICKMAN ; M. HELLARD ; T. ROBERTS ; L. CROOKS ; H. MIDGARD ; S. LARNEY ; L. DEGENHARDT ; H. ALHO ; J. BYRNE ; J. F. DILLON ; J. J. FELD ; G. FOSTER ; D. GOLDBERG ; A. R. LLOYD ; J. REIMER ; G. ROBAEYS ; M. TORRENS ; N. WRIGHT ; I. MAREMMANI ; B. L. NORTON ; A. H. LITWIN ; G. J. DORE ; International Network on Hepatitis in Substance Users |Globally, it is estimated that 71.1 million people have chronic hepatitis C virus (HCV) infection, including an estimated 7.5 million people who have recently injected drugs (PWID). There is an additional large, but unquantified, burden among th[...]NouveautéArticle : Périodique
H. L. MILLS ; C. COLIJN ; P. VICKERMAN ; D. LESLIE ; V. HOPE ; M. HICKMAN |Background: A 2006 respondent driven sampling (RDS) survey of injecting drug users (IDUs) in Bristol, UK, estimated 40 per 100 person years HCV incidence but in 2009 another RDS survey estimated only 10 per 100 person years incidence amongst the[...]